Provident Clinical Research and Consulting Inc
Glen Ellyn, Illinois, 60137, United States
NCT Number: NCT01495182
The purpose of the study will be to assess the gastrointestinal effects of a dietary fiber in healthy, adult volunteers.
Looking for future studies?
Notify Me18 year–54 year
All sexes
Interventional
Not applicable
Glen Ellyn, Illinois, 60137, United States
The study is a blinded, cross-over design with subjects completing three, two-week treatment periods, separated by two, two-week washouts. Volunteers will consume a dietary fiber for two of the treatment periods at two dose levels. The fiber will be added to foods and dispensed to subjects to be consumed twice a day during each treatment period. During the control period, subjects will receive the same study foods, but with no added fiber. Major outcomes will include fecal weight, and responses to questionnaires that assess fecal characteristics, bowel habits and gastrointestinal tolerability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A proprietary fiber will be given to subjects
Time frame: subjects will report weekly for 6 weeks
Questionnaire to assess symptoms such as nausea, bloating, and flatulence
Time frame: subjects will collect fecal output for 12 days within a six-week period
Fecal weight and stool characteristics will be measured
Ingredion Incorporated
Industry
A Double-blind, Randomized, Crossover Trial to Assess the Gastrointestinal Tolerability of a Dietary Fiber Ingredient in Healthy Men and Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07142486
Digestive Health, Gastrointestinal Health
Montreal, Quebec, Canada
View Trial DetailsNCT07618026
Gastrointestinal Health
Fort Collins, Colorado, United States
View Trial DetailsNCT07264465
Gastrointestinal Health, Gut Health
Las Vegas, Nevada, United States
View Trial DetailsNCT06628869
Digestive Health, FODMAP Intolerance
Addison, Illinois, United States
View Trial Details